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Abstract: Understanding the neurobiological processes that contribute to the 
establishment and expression of stress-induced regulation of cocaine use in 
addicted individuals is important for the development of new and better 
treatment approaches. It has been previously shown that rats self-
administering cocaine under long-access conditions (6 h daily) display 
heightened susceptibility to the reinstatement of extinguished cocaine seeking 
by a stressor, electric footshock, or i.c.v. administration of the stressor-
responsive neuropeptide, corticotropin-releasing factor (CRF). This study 
tested the hypothesis that adrenal responsiveness during earlier long-access 
cocaine self-administration (SA) is necessary for the establishment of later 
CRF-dependent stress-induced reinstatement. Reinstatement by footshock, 
but not a cocaine challenge (10 mg/kg, i.p.) following long-access SA, was 
blocked by i.c.v. administration of the CRF receptor antagonist, α-helical 
CRF9−41 (10 μg). Elimination of SA-induced adrenal responses through surgical 
adrenalectomy and diurnal corticosterone replacement (ADX/C) before 14 
days of SA under long-access conditions had minimal impact on cocaine SA, 
but blocked later footshock-induced reinstatement. By contrast, ADX/C after 
SA, but before extinction and reinstatement testing, failed to reduce 
footshock-induced reinstatement. Likewise, ADX/C before 14 days long-
access SA prevented later reinstatement by i.c.v. CRF (0.5 or 1.0 μg). 
However, significant CRF-induced reinstatement was observed when rats 
underwent ADX/C following SA, but before extinction and reinstatement 
testing, although a modest but statistically nonsignificant reduction in 
sensitivity to CRF's reinstating effects was observed. Taken together, these 
findings suggest that adrenal-dependent neuroadaptations in CRF 
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responsiveness underlie the increased susceptibility to stress-induced relapse 
that emerges with repeated cocaine use. 
Keywords: relapse, stress, CRF, CRH, glucocorticoid, cocaine 
Introduction 
The unpredictable relapse of drug use that emerges even after 
extended periods of drug abstinence is a major obstacle to the 
effective management of cocaine addiction. This chronically relapsing 
nature of addiction is likely attributable to neuroplasticity that emerges 
in an intake-dependent manner as a consequence of repeated drug 
use and can be studied in rats using the reinstatement approach. A 
large body of evidence suggests that stressful life events can 
precipitate or promote drug relapse. Reports that stressors can 
provoke craving in human cocaine addicts (Sinha et al, 1999, 2000) 
are paralleled by findings that stressors can reinstate extinguished 
cocaine seeking in rats (Ahmed and Koob, 1997; Erb et al, 1996). 
One approach that can be used to investigate persistent drug-
induced neuroplasticity related to stress-induced relapse involves the 
study of rats provided chronic daily prolonged access to cocaine for 
self-administration (SA) (Ahmed and Koob, 1998). We have previously 
reported that rats provided long access to cocaine for SA each day 
(long-access rats), but not rats provided shorter drug access, show 
robust reinstatement in response to a stressor, uncontrollable electric 
footshock, when measured several weeks after SA (Mantsch et al, 
2008a). This finding suggests that cocaine SA produces intake-
dependent, long-term neuroadaptations that lead to a heightened 
susceptibility to engage in cocaine seeking during times of stress. 
Understanding the neurobiological processes that underlie the 
establishment and expression of stressor-induced cocaine use in 
addicted individuals should facilitate the development of new and 
better treatment approaches, particularly for subpopulations of cocaine 
addicts whose drug use is stress driven. 
A role for the neuropeptide, corticotropin-releasing factor (CRF), 
in stress-induced cocaine seeking has been established. CRF receptor 
antagonists block stress-induced reinstatement (Erb et al, 1998; Lee 
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et al, 2003; Lu et al, 2001; Shaham et al, 1998; Wang et al, 2007) 
while delivery of CRF directly into the brain reinstates (Erb et al, 2006; 
Mantsch et al, 2008a). We have previously reported that, similar to 
what is observed with footshock, reinstatement by i.c.v. CRF is 
augmented following long-access SA (Mantsch et al, 2008a). These 
findings are consistent with reports that CRF regulation of addiction-
related neurocircuitry requires a previous history of drug exposure 
(Wang et al, 2005). Interestingly, the role for CRF in cocaine seeking 
has been reported to depend on the reinstating stimulus. CRF 
antagonists block reinstatement following stress, but not following a 
priming injection of cocaine in rats with limited drug intake (Erb et al, 
1998; Lee et al, 2003; Lu et al, 2001; Shaham et al, 1998; Wang et 
al, 2007; but see, Przegaliński et al, 2005). However, the contribution 
of CRF to the augmented stressor- and cocaine-induced reinstatement 
observed in rats with a history of cocaine SA under long-access 
conditions remains to be determined. The reported ability of CRF 
antagonists to attenuate cocaine SA by long-access, but not short-
access rats (Specio et al, 2008) suggests that intake-dependent 
alterations within the CRF system may establish CRF regulation of 
cocaine responsiveness in a manner that promotes drug-seeking 
behavior. In this study, we examined the role of CRF in reinstatement 
by cocaine and footshock in rats with a history of long-access SA using 
i.c.v. administration of the CRF receptor antagonist, α-helical CRF9−41. 
It has been proposed that hormonal stress responses associated 
with drug use contribute to addiction-related neuroplasticity through 
the regulation of CRF actions on neurocircuitry subserving motivation 
and reward (Kreek and Koob, 1998; Koob and Kreek, 2007). We have 
reported that an intact adrenal response at the time of earlier drug SA 
is necessary for the establishment of neuroadaptations that lead to 
heightened cocaine seeking (Mantsch and Katz, 2007; Mantsch et al, 
2008b). Our findings are consistent with previous reports that 
eliminating cocaine-induced adrenal responses during the induction 
phase prevents the later expression of stress- and cocaine-induced 
sensitization (Rouge-Pont et al, 1995; Prasad et al, 1996, 1998; 
Przegaliński et al, 2000; de Jong et al, 2007). In this study, we 
examined the effects of eliminating the adrenal response to long-
access cocaine SA through adrenalectomy along with diurnal 
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corticosterone replacement (ADX/C) before 14 days of long-access (ie, 
6-h) SA on later i.c.v. CRF- and footshock-induced reinstatement. To 
confirm that the loss of adrenal activity at the time of earlier drug 
exposure and not later reinstatement testing contributed to effects on 
drug-seeking behavior, separate groups of rats were tested for 
reinstatement after undergoing ADX/C after a 14-day period of long-
access SA, but before extinction training and reinstatement testing (ie, 
after SA-induced adaptations were already in place). 
The results of this study suggest that stressor- but not cocaine-
induced reinstatement in long-access rats is CRF dependent and that 
the establishment of later CRF and CRF-dependent footshock-induced 
reinstatement requires increased adrenal, presumably glucocorticoid, 
activity at the time of earlier long-access cocaine SA. 
Materials and Methods 
Subjects 
Ninety-two male Sprague–Dawley rats (Harlan Laboratories, St 
Louis, MO), approximately 90 days old (325 g) were used. Rats were 
housed individually in a temperature- and humidity-controlled, 
AAALAC-accredited facility under a 12 h/12 h reversed light/dark cycle 
(lights off at 0700 hours) and had access to food and water at all 
times. Procedures were carried out in accordance with the NIH Guide 
for the Care and Use of Laboratory Animals. 
Catheter Implantation 
Rats were implanted with indwelling silicon (Silastic; Dow 
Corning, Midland, MI; 0.64 mm i.d.; 1.19 mm o.d.) catheters under 
ketamine HCl (100 mg/kg, i.p.) and xylazine (2 mg/kg, i.p.) anesthesia 
(Mantsch et al, 2008b). Catheters were connected to back-mounted 
cannulae (Plastics One, Roanoke, VA) attached using dental acrylic to 
pieces of polypropylene monofilament surgical mesh (Atrium Medical, 
Hudson, NH) to permit connection of polyurethane delivery lines 
(0.51 mm i.d. × 1.52 mm o.d.) encased in stainless-steel spring 
leashes (Plastics One). Lines were connected to syringes in pumps 
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(Razel, Stamford, CT) via fluid swivels (Instech Lab., Plymouth 
Meeting, PA) suspended above the chambers. Swivel/leash assemblies 
were balanced to permit unrestrained movement. Rats recovered for 3 
days before SA, which time they received acetaminophen (480 mg/l) in 
their drinking water. 
SA Apparatus 
Operant conditioning chambers encased in sound attenuating 
cubicles (MED-Associates, St Albans, VT) and equipped with 
retractable levers with stimulus lights located above each lever were 
used for SA. One lever and light were mounted on the front wall of the 
chamber. A second lever and light were located on the back wall. 
SA and Extinction 
Following recovery from surgery, rats were trained to self-
administer cocaine (1.0 mg/kg/inf, i.v., NIDA Drug Supply Program, 
Bethesda, MD) by pressing a lever under an FR1 schedule during 2-h 
sessions, within which the active (front) lever was extended into the 
chamber and the corresponding stimulus light was illuminated. 
Pressing this lever resulted in a cocaine infusion (200 μl over 5.0 s), 
followed by a 25-s period during which the stimulus light was 
extinguished, but the lever remained extended. Inactive (back) lever 
responding was recorded, but had no programmed consequences. 
Once significant SA under the FR1 schedule was observed (>10 
infusions), the requirements for SA were gradually increased until rats 
were self-administering under an FR4 schedule. After stable 
responding was observed under the FR4 schedule (<10% variation 
from the mean over three sessions), rats underwent ADX/C or sham 
procedures and/or were provided access to cocaine during daily 6-h 
(long-access) sessions for 14 days. 
Experiment 1: Role of CRF in Cocaine- and Stress-
Induced Reinstatement after Long-Access SA 
Ten rats were tested for the role of CRF in cocaine- and 
stressor-induced reinstatement following SA using i.c.v. administration 
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of the CRF-R1/2 receptor antagonist α-helical CRF9−41 (Sigma-Aldrich, 
St Louis, MO) before reinstatement testing. At the time of 
catheterization, these rats were implanted with a 2.1-cm 23-gauge 
guide cannula into the left or right lateral ventricle using coordinates 
from Paxinos and Watson (1998): −1.0 mm a/p bregma; ±1.4 mm m/l 
midline; and −3.77 mm d/v dura (Mantsch et al, 2008a). Injections 
were performed via a microinjector, which extended 1-mm below the 
tip of the guide. After recovery from surgery, rats were trained to self-
administer and tested under long-access conditions for 14 days, 
followed by 10 days of extinction. After extinction, separate groups of 
rats were tested for reinstatement during 2-h sessions that followed a 
period of electric footshock (n=5) or a cocaine challenge (n=5) 10 min 
after i.c.v. delivery of α-helical CRF9−41 (10 μg in 1 μl over 1 min) or 
vehicle (sterile water). Each rat was tested twice for reinstatement in 
counterbalanced sequence, once with cocaine or footshock in 
combination with i.c.v. α-helical CRF9−41 and once with vehicle. Before 
the second test, rats underwent an additional extinction session. 
Electric footshock was delivered though the stainless-steel grid floors 
of the SA chambers for 15 min before the 2-h session, which was 
otherwise identical to extinction conditions. During the 15-min 
footshock period, the house light was illuminated and the levers were 
retracted and stimulus lights extinguished. Shocks (0.5 mA, 0.5 s in 
duration) were delivered an average of every 40 s (range 10–70 s). We 
have reported that these parameters produce robust reinstatement 
after long-access, but not short-access, SA (Mantsch et al, 2008a). 
Cocaine-induced reinstatement testing was conducted for 2 h 
immediately following a cocaine injection (10 mg/kg, i.p.). 
Reinstatement was defined as responding on the previously active 
lever and compared with the preceding extinction session. 
Experiment 2: Effects of ADX/C on Footshock-Induced 
Reinstatement 
To examine the role of the adrenal response in the 
establishment and expression of footshock-induced reinstatement, rats 
underwent bilateral ADX via the dorsal approach under ketamine and 
xylazine anesthesia and received ADX/C (Mantsch and Katz, 2007) 
before or after 14 days of cocaine SA or received sham treatments. 
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Diurnal corticosterone replacement consisted of s.c. implantation of a 
25% corticosterone (Sigma-Aldrich) pellet in the nape of the neck to 
produce blood concentrations similar to those found at the nadir of the 
diurnal cycle along with inclusion of 0.025% corticosterone in the 
drinking water to emulate the circadian peak observed during the 
active (dark) phase, within which most drinking occurs (Jacobson et al, 
1988). Pellets were made by melting a 1 : 3 corticosterone : cholesterol 
ratio mixture over a flame and pouring it into a mold, creating a 1.5 × 
0.5 × 0.5 cm3 (l × w × h) pellet (Meyer et al, 1979). Corticosterone 
was dissolved in ethanol before introduction into the drinking water, 
resulting in a final ethanol concentration of 1 ml/l (0.0001%). To 
replace depleted sodium secondary to the loss of aldosterone as a 
result of ADX, drinking water for all rats (ADX/C and sham) consisted 
of a 0.9% NaCl solution. Corticosterone pellets were replaced every 7 
days under sodium methohexital (1.5 mg, i.v.) sedation. Sham rats 
were implanted with 100% cholesterol pellets. Sham operations were 
identical to ADX surgeries, except that, once exposed, the adrenal 
glands were not removed. Before undergoing ADX/C or sham 
procedures, rats were trained to self-administer cocaine during 2-h 
sessions. After recovery, rats were allowed to self-administer again 
until stable response patterns were re-established, at which time long-
access SA testing began, followed by extinction and testing for 
footshock-induced reinstatement. A third group of rats was used to 
examine the effects ADX/C after SA, but before extinction on later 
footshock-induced reinstatement. These rats underwent the ADX/C 
procedure after 14 days of SA and were allowed to recover before the 
10-day extinction period and reinstatement testing. 
Experiment 3: Effects of ADX/C on CRF-Induced 
Reinstatement 
ADX/C effects on reinstatement by i.c.v. CRF were tested in a 
separate group of rats implanted with a cannula into a lateral ventricle 
at the time of catheterization. Following recovery and SA training, 
these rats underwent ADX/C or sham treatments before SA and 
extinction. After extinction, each rat was tested for reinstatement in 
response to two concentrations of CRF and sterile water vehicle in 
counterbalanced sequence. During reinstatement testing rats received 
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an i.c.v. 1-μl infusion of CRF (0.5 or 1 μg; Sigma-Aldrich) or vehicle 
over a 1-min period 15 min before placement into the chambers for 2 h 
(Mantsch et al, 2008a). A third group of rats underwent ADX/C after 
14 days of SA and, following a 3–4 day recovery period, went through 
10 days of extinction before testing for CRF-induced reinstatement. In 
all cases, rats with confirmed injection sites outside of the lateral 
ventricle were excluded from data analyses. 
Measurement of Plasma Corticosterone 
When possible, blood (100 μl per sample) was acquired via the 
catheters for the measurement plasma corticosterone under basal 
conditions and during SA. Samples were acquired before (at 0800 
hours, just after the start of the dark phase) and after the 6-h SA 
sessions (at 1400 hours) and at the corresponding baseline time 
points. In addition, samples were acquired after 2 h of SA (at 1000 h) 
and at the corresponding baseline time from a separate group of rats 
for examination of corticosterone at an earlier time during the SA 
sessions. The days on which blood samples were taken varied across 
the 14-day test period such that about half of the rats were sampled 
during the first 7 days and the other half during the final 7 days of SA. 
In addition, 12 rats (six ADX/C and six sham) implanted with a lateral 
ventricle cannula were used to examine the plasma corticosterone 
responses to footshock and i.c.v. CRF. These rats underwent i.c.v. 
cannula implantation and ADX/C or sham procedures before testing for 
footshock- and CRF-induced corticosterone responses. Corticosterone 
was measured using radioimmunoassay kits (MP Biochemicals, Irvine, 
CA). Blood was collected on ice in tubes containing heparin and 
centrifuged to separate plasma, which was frozen at −80°C. Samples 
were analyzed in duplicate. 
Statistical Analyses 
Statistical analyses were conducted using Predictive Analytics 
SoftWare statistics software (SPSS, Chicago, IL). Statistical 
significance was determined using ANOVA, followed, when appropriate, 
by further analyses of main effects using ANOVA and/or post hoc 
testing using Bonferroni-corrected t-tests, unless indicated otherwise. 
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Results 
Experiment 1: Role of CRF in Cocaine- and Stress-
Induced Reinstatement after Long-Access SA 
Five rats were tested for the effects of i.c.v. α-helical CRF9−41 on 
cocaine-induced reinstatement following long-access SA and five were 
tested for the effects of i.c.v. α-helical CRF9−41 on reinstatement by 
footshock. Cocaine SA by the rats used for Experiment no. 1 is shown 
in Figure 1. As reported previously, a progressive escalation of SA was 
observed (one-way ANOVA; F13, 117=2.917; P=0.001), with a significant 
increase in SA on day 13 of testing (two-tailed Dunnett's t-test; 
P=0.05). Extinction and cocaine- and footshock-induced reinstatement 
of cocaine seeking following i.c.v. administration of the CRF receptor 
antagonist α-helical CRF9−41 (10 μg) or vehicle are shown in Figure 2. 
Reinstatement by footshock (Figure 2A), but not cocaine (Figure 2B), 
was blocked by i.c.v. delivery of α-helical CRF9−41 in rats with a history 
of long-access SA. Two-way ANOVA showed significant overall 
footshock (F1, 4=7.726; P<0.05) and cocaine (F1, 4=9.146; P<0.05) 
reinstatement effects. A significant interaction was found between α-
helical CRF9−41 pretreatment and shock-induced (F1, 4=7.323; P=0.05), 
but not cocaine-induced, reinstatement. 
 
Figure 1 Cocaine self-administration (SA) under long-access conditions. Data 
represent intravenous (i.v.) cocaine (1.0 mg/kg/inf) SA (infusions/6-h session±SE) in 
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rats tested for the effects of intracerebroventricular (i.c.v.) α-helical corticotropin-
releasing factor (CRF)9−41 on later cocaine- and electric footshock-induced 
reinstatement. Rats showed a progressive escalation of cocaine SA, with a significant 
increase in cocaine intake on day 13 of testing (two-tailed Dunnett's test vs SA day 1; 
*P=0.05). 
 
 
Figure 2 Central corticotropin-releasing factor (CRF) receptor antagonism blocks 
stress- but not cocaine-induced reinstatement. Data represent responding during the 
reinstatement sessions preceded by 15-min of intermittent electric footshock (n=5; a) 
or a 10 mg/kg (i.p.) cocaine challenge (n=5; b) in rats pretreated with an 
intracerebroventricular (i.c.v.) injection of the CRF receptor antagonist α-helical 
CRF9−41 (10 μg) or vehicle or during the corresponding extinction session. Footshock 
reinstated extinguished cocaine seeking following pretreatment with vehicle, but not α-
helical CRF9−41 (#P<0.05 vs extinction and i.c.v. vehicle). By contrast, cocaine-induced 
reinstatement was observed following pretreatment with either α-helical CRF9−41 or 
vehicle (*P<0.05 vs extinction). 
Cocaine SA and Extinction in Rats used for Experiments 
2 and 3 
Effects of ADX/C on cocaine SA  
Cocaine SA by sham-treated rats (n=28) and rats that 
underwent ADX/C before 14 days of long-access SA (n=30; pre-SA 
ADX) or after 14 days of SA (n=24; post-SA ADX) is shown in Figure 
3a. Data from rats tested for later footshock- and CRF-induced 
reinstatement were combined for this analysis. Two-way ANOVA 
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showed a significant overall main effect of SA day (F13, 1027=10.400; 
P<0.001) and ADX condition (F2, 79=4.605; P<0.05), but did not show 
a significant SA day × ADX condition interaction. SA was increased on 
days 4–14 compared with day 1 (P<0.05) and, overall, SA was 
modestly, but significantly, reduced in rats that underwent ADX/C 
before SA compared with rats that underwent ADX/C after SA 
(P<0.05), but, surprisingly, not compared with sham-treated controls. 
No differences across ADX/C conditions on the first day of SA testing 
were found. 
 
Figure 3 Cocaine self-administration (SA) and SA-induced increases in plasma 
corticosterone in sham and adrenalectomy and diurnal corticosterone replacement 
(ADX/C)-treated rats. Data in (a) represent intravenous (i.v.) cocaine SA (infusions/6-
h session±SE) in rats that underwent adrenalectomy and diurnal corticosterone 
replacement before 14 days of SA testing (pre-SA ADX/C; n=30) or after 14 days of 
SA, but before extinction and testing for corticotropin-releasing factor (CRF)- or 
footshock-induced reinstatement (post-SA ADX/C; n=24) or underwent a sham 
treatment (n=28). Significant escalation of SA was observed in all groups and, overall, 
SA was reduced in pre-SA ADX/C rats relative to post-SA ADX/C- but not sham-
treated rats (#P<0.05). Data in (b) represent plasma corticosterone (CORT) 
(ng/ml±SE) measured at 0800 hours (a time corresponding to the start of the daily SA 
session), 1000 hours (a time corresponding to a point 2 h into the SA session), and 
1400 hours (a time corresponding to the completion of the 6-h SA session) in sham-
treated rats under basal conditions (Sham Baseline) or during SA (Sham baseline) or 
in ADX/C-treated rat during SA (ADX/C SA). In sham-treated rats, cocaine SA 
increased plasma corticosterone relative to basal levels. During SA, ADX/C rats 
showed that corticosterone values were similar to baseline levels and significantly 
lower than levels during SA in sham-treated rats (*P<0.001 vs sham baseline and 
ADX/C SA; **P<0.05 vs sham SA only). 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuropsychopharmacology, Vol. 36, No. 7 (June 2011): pg. 1444-1454. DOI. This article is © Nature Publishing Group 
(Macmillan Publishers Limited) and permission has been granted for this version to appear in e-Publications@Marquette. 
Nature Publishing Group (Macmillan Publishers Limited) does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Nature Publishing Group (Macmillan 
Publishers Limited). 
13 
 
SA-Induced Increases in Plasma Corticosterone 
SA-induced increases in plasma corticosterone in sham-treated 
and ADX/C rats are shown in Figure 3b. As we did not acquire samples 
from every rat in each group at each time point, we used a 3 × 3 two-
way independent measures ANOVA to examine corticosterone at three 
time points corresponding to the times just before SA testing (ie. at 
0800 hours), 2 h into SA testing (ie, at 1000 hours), and just after the 
6-h SA session (ie, at 1400 hours) under basal conditions and in 
response to SA. The ANOVA did not show a significant overall effect of 
time-of-day, although a clear diurnal pattern of corticosterone 
fluctuation was observed under basal conditions in sham-treated rats 
with peak levels at the 0800 hours time point corresponding to the 
start of the dark phase and the low point at 1400 hours, 6 h into the 
dark phase. A significant overall effect of treatment condition (baseline 
vs sham SA vs ADX/C SA; F2, 182=9.566; P<0.0001) and a significant 
treatment condition × time-of-day interaction (F4, 186=5.151; P<0.001) 
were observed. Comparison across treatments using one-way ANOVA 
at each of the three time showed significant main effects at the 1000 
hours (F2, 30=11.833; P<0.001) and 1400 hours (F2, 65=3.850; P<0.05), 
but not the 0800 hours (ie, pre-SA), time point. Overall corticosterone 
levels were significantly higher in sham-treated rats during SA 
compared with basal conditions (P<0.001). SA-induced increases in 
corticosterone were prevented by ADX/C treatment. Corticosterone 
levels were significantly reduced during SA in ADX/C rats compared 
with sham-treated controls (P<0.05). By contrast, corticosterone 
levels in ADX/C rats during SA did not differ from basal corticosterone 
levels and did not differ between ADX/C rats during SA and baseline 
values in sham-treated rats. At the 1400 hours time point, 
corticosterone levels in self-administering sham rats were also 
significantly higher than that during sham baseline conditions 
(P<0.05). However, the difference between sham and ADX/C SA rats 
at this time point did not reach statistical significance. 
Effects of ADX/C on Extinction Responding 
Extinction of cocaine SA in sham-treated rats (n=28) and rats 
that underwent ADX/C before 14 days of SA (n=30; pre-SA ADX) or 
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after 14 days of SA, but before extinction and reinstatement testing 
(n=24), is shown in Figure 4. Two-way ANOVA showed significant 
main effects of extinction day (repeated measure; F9, 711=67.704; 
P<0.0001) and ADX condition (F2, 79=7.29; P=0.001), but no ADX 
condition × extinction day interaction. As expected, responding 
progressively decreased across the 10 days of extinction training. 
Overall, responding was significantly lower in pre-SA ADX rats 
compared with rats that received sham treatments and rats that did 
not receive ADX/C until after the SA phase of the study, but before 
extinction (Figure 4b), suggesting that adrenal activity at the time of 
cocaine SA, but not during extinction itself, contributed to drug-
seeking behavior during the extinction sessions. 
 
Figure 4 Extinction of cocaine self-administration (SA) in sham- and 
adrenalectomy and diurnal corticosterone replacement (ADX/C)-treated rats. Data 
represent responding during extinction in rats that underwent ADX and corticosterone 
replacement before 14 days of SA testing (pre-SA ADX/C; n=30) or after 14 days of 
SA but before (post-SA ADX/C; n=24), or sham controls (n=28) shown as daily 
responding during each of the 10 days of extinction (responses/2-h session±SE; a) or 
total responding collapsed across all 10 days (±SE; b). Overall, extinction responding 
was significantly decreased in pre-SA ADX/C rats compared with either post-SA ADX/C 
rats or sham-treated controls (*P<0.05; b). 
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Experiment 2: Effects of ADX/C on Footshock-Induced 
Reinstatement 
The effects of ADX/C on footshock-induced reinstatement were 
examined in rats that underwent ADX/C before 14 days of long-access 
SA (n=18), rats that underwent ADX/C after 14 days of SA, but before 
extinction and reinstatement (n=15), and sham-treated rats (n=16) 
and are shown in Figure 5a. A two-way footshock reinstatement × ADX 
condition ANOVA that included rats from all three ADX groups (ie, 
sham, pre-SA ADX/C, and post-SA ADX/C) showed significant main 
effects of shock (F1, 46=27.730; P<0.001) and ADX treatment 
(F2, 46=3.768; P<0.05) on cocaine seeking as well as a significant 
interaction between footshock and ADX treatment (F2, 46=3.231; 
P<0.05). Post hoc testing showed that significant footshock-induced 
reinstatement occurred in sham-treated and post-SA ADX/C, but not 
pre-ADX/C rats (P<0.05 vs extinction). Further, footshock-induced 
lever pressing was significantly reduced in pre-SA ADX/C, but not 
post-SA ADX/C rats, compared with sham controls (P<0.01), even 
though responding under extinction conditions was not different. 
 
Figure 5 Stressor-induced reinstatement and increases in plasma corticosterone in 
sham- and adrenalectomy and diurnal corticosterone replacement (ADX/C)-treated 
rats. Data in (a) represent responding during the reinstatement sessions preceded by 
15 min of intermittent electric footshock or during the preceding extinction session in 
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pre-self-administration (SA) ADX/C (n=18)-, post-SA ADX/C (n=15)-, and sham-
treated (n=16) rats following long-access (6-h daily) SA. Footshock-induced 
reinstatement was prevented by ADX/C before (pre-SA ADX/C), but not after (post-SA 
ADX/C) long-access cocaine SA (*significant reinstatement, P<0.05 vs extinction; 
#significant decrease vs sham, P<0.05). Data in (b) represent the effects of footshock 
on plasma corticosterone (ng/ml±SE) in ADX/C (n=6)- and sham-treated (n=6) rats. 
ADX/C prevented footshock-induced increases in plasma corticosterone (*P<0.01 
shock vs baseline; #P<0.001 ADX/C vs sham). 
Effects of ADX/C on Footshock-Induced Increases in 
Plasma Corticosterone 
To confirm that our ADX/C approach eliminated footshock-
induced increases in plasma corticosterone, the response to footshock 
following sham treatment or ADX/C was determined in a separate 
group of 12 rats (n=6, ADX/C and n=6, sham) and is shown in Figure 
5b. As expected, ADX/C eliminated footshock-induced increases in 
corticosterone. Two-way ANOVA showed a significant overall effect of 
footshock (F1, 10=13.777) and ADX condition (F1, 10=67.797) on plasma 
corticosterone (P<0.001 for each) and a significant shock × ADX 
condition interaction (F1, 10=25.199, P=0.001). Footshock significantly 
increased plasma corticosterone in sham-treated (P<0.01 vs baseline), 
but not ADX/C, rats. Further, plasma corticosterone following 
footshock was significantly higher in sham-treated compared with 
ADX/C rats (P<0.05), whereas differences in basal corticosterone 
levels were not observed. 
Experiment 3: Effects of ADX/C on CRF-Induced 
Reinstatement 
As we have previously reported that, like footshock, 
reinstatement by i.c.v. CRF is augmented after long-access SA 
(Mantsch et al, 2008a) and because shock-induced reinstatement in 
rats after long-access SA is CRF dependent (Figure 2), we examined 
the role of adrenal activation at the time of earlier SA testing on later 
CRF-induced reinstatement. The effects of ADX/C on CRF-induced 
reinstatement were examined in 12 rats that underwent ADX/C before 
14 days of SA, nine rats that underwent ADX/C after 14 days of SA, 
but before extinction and reinstatement, and 14 sham-treated rats and 
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are shown in Figure 6a. Two-way CRF × ADX condition ANOVA showed 
significant main effects of CRF delivery (F2, 60=5.396; P<0.01) and ADX 
condition (F2, 30=3.382; P<0.05), but did not show a significant CRF × 
ADX condition interaction. Post hoc testing showed overall dose-
dependent reinstatement by CRF, with significant reinstatement 
observed at the 0.5 μg CRF dose (P<0.05), but not the 1.0 μg dose 
(P=0.058), when compared with vehicle pretreatment. Overall, 
reinstatement was significantly reduced in the pre-SA ADX/C group 
compared with sham controls (P<0.05), but not in the post-SA ADX/C 
group. To determine if CRF induced reinstatement in each of the ADX 
groups, a planned analysis of reinstatement was conducted using one-
way repeated measures ANOVA within each ADX group. Significant 
dose-dependent CRF-induced reinstatement was found in sham-
treated (P<0.01 vs vehicle), but not pre- or post-SA ADX/C, rats. 
 
Figure 6 Corticotropin-releasing factor (CRF)-induced reinstatement and increases 
in plasma corticosterone in sham and adrenalectomy and diurnal corticosterone 
replacement (ADX/C)-treated rats. Data in (a) represent responding during the 
reinstatement sessions preceded by intracerebroventricular (i.c.v.) injections of CRF 
(0.5 or 1 μg) or vehicle in pre-self-administration (SA) ADX/C (n=12)-, post-SA ADX/C 
(n=9)-, and sham-treated (n=14) rats following long-access (6-h daily) SA. Overall, 
CRF-induced reinstatement was reduced by ADX/C before (pre-SA ADX/C), but not 
after (post-SA ADX/C) long-access cocaine SA compared with sham-treated rats 
(*significant overall decrease vs sham; P<0.05). Data in (b) represent the effects of 
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i.c.v. CRF on plasma corticosterone (ng/ml±SE) in ADX/C (n=6)- and sham-treated 
(n=6) rats. ADX/C prevented CRF-induced increases in plasma corticosterone 
(*P<0.01 CRF vs baseline; #P<0.01, ADX/C vs sham). 
Effects of ADX/C on I.C.V. CRF-Induced Increases in 
Plasma Corticosterone 
To confirm that our ADX/C approach eliminated the 
corticosterone response to CRF, responses to CRF following sham or 
ADX treatments were determined in 12 rats (n=6, ADX/C and n=6, 
sham) and are shown in Figure 6b. ADX/C eliminated the 
corticosterone response to 0.5 and 1.0 μg/kg CRF. Two-way CRF 
treatment × ADX condition ANOVA showed a significant overall effects 
of CRF (F2, 20=34.709; P<0.001) and ADX/C (F1, 10=88.102; P<0.001), 
and a significant CRF treatment × ADX condition interaction 
(F2, 20=26.676, P<0.001). Further analysis using one-way ANOVA 
within each ADX condition showed that each CRF dose increased 
corticosterone in sham-treated (P<0.01 vs baseline), but not ADX/C, 
rats. Further, corticosterone was significantly higher following either 
i.c.v. CRF dose in sham-treated rats compared with ADX/C rats 
(P<0.001), whereas differences in basal levels were not observed. 
Discussion 
We have previously reported that reinstatement in response to a 
stressor, uncontrollable footshock, is observed in rats with a history of 
long-access cocaine SA (14 × 6 h per day), but not in rats with a 
history of short-access SA (14 × 2 h per day; Mantsch et al, 2008a). 
The establishment of stress-induced reinstatement in long-access rats 
is likely attributable to intake-dependent alterations in neurobiological 
processes regulated by the neuropeptide CRF, as (1) shock-induced 
reinstatement in long-access rats is blocked by i.c.v. administration of 
the CRF receptor antagonist, α-helical CRF9−41 (Figure 2); and (2) 
reinstatement by i.c.v. CRF is also augmented following long-access 
SA (Mantsch et al, 2008a). Cocaine SA under long-access conditions 
produces robust and prolonged increases in plasma corticosterone 
(Mantsch et al, 2003, 2007), and elimination of the adrenal response 
to long-access SA attenuates later cocaine-induced reinstatement 
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(Mantsch et al, 2008b). In this paper, we show that CRF-dependent 
stress-induced reinstatement and reinstatement by CRF also rely on an 
intact adrenal response at the time of earlier long-access SA. However, 
ADX/C after long-access SA, but before extinction and reinstatement, 
failed to alter shock-induced reinstatement and only modestly 
suppressed reinstatement by CRF despite eliminating shock- and CRF-
induced increases in corticosterone. Thus, although long-access SA 
increases stress-induced activation of the HPA axis (Mantsch et al, 
2007), the augmented glucocorticoid response does not contribute to 
stress-induced cocaine seeking. These data suggest that an activated 
adrenal, presumably glucocorticoid, response at the time of cocaine 
use is necessary for establishing neuroplasticity involving CRF-
responsive systems and leads to heightened susceptibility to later CRF-
dependent stress-induced relapse. 
Stressor- but not Cocaine-Induced Reinstatement is 
CRF Dependent 
Previous studies have implicated CRF in cocaine abuse (Sarnyai 
et al, 2001; Shalev et al, 2010). CRF receptor antagonists reduce 
cocaine SA (Goeders and Guerin, 2000) and these reductions are 
greater after SA under long-access conditions, implying that there is 
an intake-dependent upregulation of the CRF system (Specio et al, 
2008). For reinstatement, the role for CRF appears to depend on the 
reinstating stimulus. CRF is required for cocaine seeking induced by 
stress, but not a cocaine challenge (Erb et al, 1998; Lee et al, 2003; 
Lu et al, 2001; Shaham et al, 1998; Wang et al, 2007; but see, 
Przegaliński et al, 2005). Stress-induced reinstatement following 
heroin (Shaham et al, 1997), alcohol (Lê et al, 2000), and nicotine 
(Bruijnzeel et al, 2009) SA has also been reported to be CRF 
dependent. We extend these findings by showing that i.c.v. 
administration of the CRF receptor antagonist α-helical CRF9−41 blocks 
reinstatement by shock, but not cocaine, in rats with a history of long-
access SA. It should be noted that we only examined the effects of α-
helical CRF9−41 on reinstatement by a single, relatively high cocaine 
dose. Confirmation that CRF is not involved in cocaine-induced 
reinstatement will require testing for antagonist effects across a wider 
cocaine dose range. 
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Adrenal Responses during SA are Required for Later 
CRF- and Stress-Induced Reinstatement 
Our findings suggest that an intact adrenal response at the time 
of long-access cocaine SA is required for later CRF-dependent stressor-
induced reinstatement. Eliminating the adrenal response via ADX/C 
before long-access SA prevented later reinstatement by footshock or 
CRF. However, ADX/C treatment after a 14-day period of long-access 
SA, but before extinction and reinstatement, did not. Considering the 
role for CRF in footshock-induced reinstatement and our earlier finding 
that CRF-induced reinstatement is increased after long-access SA 
(Mantsch et al, 2008a), we hypothesized that the augmentation of 
reinstatement was attributable to an adrenal-dependent enhancement 
of CRF regulation of cocaine seeking. Accordingly, CRF-induced 
reinstatement was also prevented when rats underwent ADX/C before, 
but not after, SA testing. 
The adrenal requirement for the establishment of later stress- 
and CRF-induced reinstatement likely involves SA-induced increases in 
glucocorticoid production. Glucocorticoids secreted as a consequence 
of activation of the HPA axis play a critical role in physiological 
responses that enable organisms to effectively adapt to and cope with 
stressors (de Kloet et al, 2008) and have been proposed to participate 
in addiction-related processes (Piazza and Le Moal, 1996; Kreek and 
Koob, 1998; Marinelli and Piazza, 2002; Koob and Kreek, 2007). 
Glucocorticoid receptors are found in brain regions implicated in 
addiction (eg, the ventral tegmental area (VTA) and ventral striatum; 
Harfstrand et al, 1986), where repeated/prolonged elevation of 
glucocorticoids has been reported to induce morphological changes 
that may have long-term implications for cocaine seeking (Wellman, 
2001; Morales-Medina et al, 2009). Consistent with this, elevated 
corticosterone has been reported to contribute to the stress-induced 
facilitation of the acquisition of cocaine SA (Campbell and Carroll, 
2001; Goeders and Guerin, 1996; Mantsch et al, 1998), cocaine- and 
stress-induced sensitization of cocaine's locomotor-stimulating effects 
(Prasad et al, 1996, 1998; Rouge-Pont et al, 1995; Przegaliński et al, 
2000; Wei et al, 2004; de Jong et al, 2007), and stress-induced 
escalation of cocaine SA (Mantsch and Katz, 2007). Like stress, 
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cocaine SA elevates circulating glucocorticoid levels in rats (Galici et al, 
2000; Mantsch et al, 2003), monkeys (Broadbear et al, 1999a), and 
human addicts (Ward et al, 1999). Not surprisingly, when rats self-
administer cocaine under long-access conditions, the increase in 
corticosterone is prolonged, matching the duration of drug exposure 
and potentially rendering these rats more susceptible to later cocaine 
seeking (Mantsch et al, 2003, 2008b). 
Role of Glucocorticoids in Stress- and CRF-Induced 
Reinstatement 
In contrast to the effects of ADX/C before SA, ADX/C after long-
access cocaine SA did not alter footshock-induced reinstatement, 
despite eliminating the corticosterone response to shock. This is 
consistent with reports that acute stress-induced increases in 
corticosterone are not necessary for reinstatement following cocaine or 
heroin SA (Shaham et al, 1997; Erb et al, 1998; Shalev et al, 2006). 
These findings parallel clinical reports that although drug-, cue- and 
stress-induced drug craving are accompanied by activation of the HPA 
axis (Berger et al, 1996; Ward et al, 1999; Sinha et al, 2003), 
pharmacological inhibition of glucocorticoid secretion has little or no 
effect on evoked craving in cocaine-dependent individuals (Harris et al, 
2004; Winhusen et al, 2005). Although significant reductions in CRF-
induced reinstatement were not observed in rats that underwent 
ADX/C after long-access SA, cocaine seeking in these rats tended to be 
reduced, particularly at the lower (ie, 0.5 μg) CRF dose when 
compared with sham levels and significant reinstatement relative to 
vehicle treatment was not observed. For this reason, we are reluctant 
to rule out the possibility that the acute glucocorticoid response to CRF 
delivery contributed to reinstatement. 
Role for SA-Induced Adrenal Responses in Cocaine SA 
and Escalation 
Consistent with previous findings (Ahmed and Koob, 1998; 
Mantsch et al, 2004), a progressive escalation of cocaine intake was 
observed with repeated long-access SA. It has been suggested that 
escalated SA reflects the loss of control over drug use that is central to 
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human cocaine addiction. As reported previously (Mantsch and Katz, 
2007; Mantsch et al, 2008b), ADX/C failed to alter SA before 
escalation (ie, on the first day of testing), consistent with reports in 
monkeys and human addicts that increased glucocorticoid secretion by 
cocaine is not necessary for its acute reinforcing effects (Broadbear et 
al, 1999b; Ward et al, 1999). Others have shown that complete 
elimination of glucocorticoids by surgical or pharmacological ADX in 
the absence of corticosterone replacement attenuates cocaine SA in 
rats (Goeders and Guerin, 1996; Deroche et al, 1997). However, as 
was the case in this study, SA is restored when diurnal patterns of 
circulating corticosterone levels are re-established (Deroche et al, 
1997). 
We previously reported that, despite the lack of an initial effect 
on SA, ADX/C slows the escalation of SA that emerges under long-
access conditions (Mantsch et al, 2008b). In this study, escalation was 
observed in both ADX/C and sham-treated rats. However, modest, but 
significant overall reductions in SA were observed in pre-SA ADX/C 
rats when compared with post-SA ADX/C, but not sham, rats. It is 
notable that, although not statistically significant, SA in sham-treated 
rats was also reduced compared with post-SA ADX/C rats, suggesting 
that nonspecific effects of the surgical procedure may have contributed 
to the difference. 
Potential Role of Non-Glucocorticoid Adrenal Responses 
Although we presume that the effects of ADX were attributable 
to prevention of the SA-induced glucocorticoid response, we cannot 
rule out the possibility that elimination of other adrenal hormones, 
including epinephrine released from the adrenal medulla or adrenal 
cortical steroids such as aldosterone, dehydroepiandrosterone, and 
deoxycorticosterone, contributed to our effects. It has been reported 
that the prevention of cocaine-induced behavioral sensitization in mice 
by surgical ADX is reversed if both corticosterone and epinephrine are 
co-administered with cocaine during induction, suggesting a potential 
cooperative role between glucocorticoids and epinephrine in the 
establishment of cocaine-induced neuroplasticity (de Jong et al, 2009). 
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Effects of ADX/C on Extinction after SA 
Despite minimal differences in drug intake, extinction 
responding was significantly reduced in rats that underwent ADX/C 
before SA. As rats that did not undergo ADX/C until after SA did not 
display similar reductions in extinction responding, these findings 
suggest that adrenal responses at the time of earlier SA likely led to 
an overall increase in responding during extinction. To the extent that 
adrenal-dependent alterations in motivation to engage in cocaine 
seeking contributed to augmented reinstatement, it is possible that 
such changes also resulted in heightened drug seeking during 
extinction. Alternatively, adrenal activation during SA may promote 
the formation and/or consolidation of drug-related memories. A role 
for glucocorticoids in memory consolidation has been established 
(Sandi, 1998; Roozendaal, 2002). The extent to which this may have 
contributed to the attenuation of later reinstatement is unclear. 
Adaptations in CRF Systems and Heightened 
Susceptibility to Stress-Induced Drug Seeking 
Our findings that CRF-induced reinstatement is augmented in an 
intake-dependent manner following SA is consistent with reports that 
the locomotor and c-fos responses to i.c.v. CRF are increased after 
repeated cocaine (Erb et al, 2003, 2005). Repeated cocaine also 
produces widespread alterations in CRF receptor binding (Goeders et 
al, 1990) and increases CRF responsiveness throughout the brain, 
including in the lateral septum (Liu et al, 2005), hippocampus (Guan 
et al, 2009), amygdala (Orozco-Cabal et al, 2008; Erb et al, 2005; 
Pollandt et al, 2006), VTA (Wang et al, 2005; Hahn et al, 2009), and 
bed nucleus of the stria terminalis (BNST; Francesconi et al, 2009). 
These latter two regions (ie, the VTA and BNST) have been implicated 
in CRF-induced cocaine seeking (Erb and Stewart, 1999; Erb et al, 
2001; Wang et al, 2005) and may therefore represent sites at which 
cocaine-induced adaptations that contribute to reinstatement occur. 
Although our findings suggest that heightened stress-induced 
reinstatement is largely attributable to increased CRF responsiveness 
related to alterations in receptors or downstream processes, others 
have reported alterations in basal and evoked CRF expression and 
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release in a number of brain regions, most notably the amygdala, 
following chronic cocaine delivery (Richter et al, 1995; Richter and 
Weiss, 1999; Zorrilla et al, 2001; Zhou et al, 2003). 
Glucocorticoid Regulation of CRF Actions 
Glucocorticoid regulation of CRF actions has been reported. In 
contrast to the hypothalamus, where chronically elevated 
corticosterone reduces CRF production, corticosterone augments basal 
and stress-evoked increases in CRF mRNA in brain regions implicated 
in stressor-induced cocaine seeking (ie, amygdala, BNST, prefrontal 
cortex; Makino et al, 1994a, 1994b, 1995; Shepard et al, 2006; Merali 
et al, 2008). These effects have been shown to contribute to 
augmented CRF-induced behavioral responses (Lee et al, 1994; 
Shepard et al, 2000). Glucocorticoids also regulate CRF receptor 
expression. Although regulation of CRF receptor expression within the 
hypothalamus and pituitary is primarily inhibitory (Kageyama et al, 
2003; Chen et al, 2005), effects in non-hypothalamic brain regions 
vary, consistent with the glucocorticoid regulation of CRF mRNA 
(Makino et al, 1995; Schulkin et al, 1998). Adrenal-dependent 
neuroplasticity may also involve brain regions downstream from sites 
of CRF action. We have found that the augmentation of CRF-
independent cocaine-induced reinstatement after long-access SA is 
also prevented by pre-SA ADX/C (Mantsch et al, 2008b), suggesting 
that adrenal-dependent adaptations in brain regions that represent a 
final common pathway for stimuli that induce cocaine seeking may 
underlie augmented reinstatement. Accordingly, it has been reported 
that glucocorticoid receptors in dopaminoceptive neurons, likely in the 
nucleus accumbens, contribute to drug seeking following repeated 
cocaine delivery, but are not necessary for responses to acute cocaine 
(Deroche-Gamonet et al, 2003; Ambroggi et al, 2009). 
Conclusions 
To summarize, this study suggests that adrenal-dependent 
alterations in CRF responsiveness underlie the increased susceptibility 
to stress-induced relapse that emerges with repeated cocaine use. 
Understanding the mechanisms through which adrenal activation 
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promotes CRF regulation of cocaine seeking should provide valuable 
insight into the addiction process and aid in the development of new 
approaches for the treatment of cocaine addicts. 
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